Projekt
A20: Metamorphose eines Tumorsuppressors
EGFR-driven lung adenocarcinoma, Tumor immune microenvironment, A20 (TNFAIP3) signaling, Immunotherapy responsiveness, STAT1/IFN signaling axis, Genetically engineered mouse models (GEMMs), Humanmedizin, Gesundheitswissenschaften, Naturwissenschaften, Biologie, Medizinisch-theoretische Wissenschaften, Pharmazie, Molek…
EGFR-driven lung adenocarcinoma, Tumor immune microenvironment, A20 (TNFAIP3) signaling, Immunotherapy responsiveness, STAT1/IFN signaling axis, Genetically engineered mouse models (GEMMs), Humanmedizin, Gesundheitswissenschaften, Naturwissenschaften, Biologie, Medizinisch-theoretische Wissenschaften, Pharmazie, Molekularbiologie, Krebsforschung